Malignant salivary gland tumours in Sweden 1960–1989—An epidemiological study
References (47)
- et al.
Salivary gland tumors in Canadian Eskimos
Cancer
(1963) - et al.
Salivary gland tumors in Uganda
Cancer
(1964) Salivary gland tumours in Malaya
British Journal of Cancer
(1967)- et al.
- Evans RW, Cruickshank AH. Epithelial Tumours of the Salivary Glands. Philadelphia, WB Saunders,...
- et al.
Incidence of salivary gland tumours in Scotland
Accuracy of national records
British Medical Journal
(1978) - et al.
Parotid tumours: A review of parotid tumour surgery in the Northern Regional Health Authority of the United Kingdom 1978–1982
British Journal of Surgery
(1988) - et al.
Salivary gland tumors in Malawi
Cancer
(1980) - et al.
Salivary gland tumors in atomic bomb survivors, Hiroshima, Japan: II. Pathologic study and supplementary epidemiologic observations
Cancer
(1983) - et al.
Benign and malignant neoplasms of the parotid gland
Incidence and histology in the Danish county of Funen
Laryngoscope
(1987)
Morbidity from cancer in the United States
Report on the status of cancer control, May 1989
Cancer registration in Denmark and the study of multiple primary cancers, 1943–80
NCI Monographs
Incidence of salivary gland neoplasms in Greenland with special reference to an anaplastic carcinoma
Acta Pathologica Microbiologica Immunologica Scandinavica
Cancer incidence patterns in the pacific basin
NCI Monographs
Classification of salivary gland neoplasms
Salivary neoplasms: Overview of a 35-year experience with 2.807 patients
Head and Neck Surgery
Salivary gland tumors in the parotid gland, submandibular gland, and the palate region
Cancer
Disease of the Salivary Glands. Pathology. Diagnosis—Treatment—Facial Nerve Surgery
Salivary gland tumours: A review of 2.410 cases with particular reference to histologic types, site, age, and sex distribution
Journal of Pathology
Tumors of the Head and Neck: Clinical and Pathological Considerations
Histologic Typing of Salivary Gland Tumours. WHO International Classification of Tumours No 4
Cited by (76)
Rates of tumour recurrences and metastases after surgical removal of malignant salivary gland tumours throughout 5-years of follow-up: A retrospective single-centre study
2019, Oral and Maxillofacial Surgery CasesCitation Excerpt :Moreover, Ladeinde et al. [7] reported that MSGTs represented 60.8% of all salivary gland tumours, while benign tumours accounted for 40.2% of their cases. Although, there are many studies [5,8–10], which have examined the demography of benign salivary gland tumours, studies examining MSGTs are rare [11,12]. General management guides for such tumours are available, but they vary from centre to centre [13,14] so the management of carcinomas are still discussable.
Salivary gland tumours in a northern Chinese population: a 50-year retrospective study of 7190 cases
2017, International Journal of Oral and Maxillofacial SurgeryMalignant sublingual gland tumors: Demographics, prognostic factors, and treatment outcomes
2016, Oral Surgery, Oral Medicine, Oral Pathology and Oral RadiologyCitation Excerpt :However, squamous cell carcinoma presented with a higher than expected frequency. It is likely that some of the squamous cell carcinomas identified in this study may have mucosal origins rather than sublingual gland origins.9 Past studies have found that most patients presented with an advanced stage at presentation (stage III or IV) because most sublingual tumors are asymptomatic.10,12,13
An epidemiological evaluation of salivary gland cancer in the Netherlands (1989-2010)
2015, Cancer EpidemiologyTumours of the salivary glands in northeastern China: A retrospective study of 2508 patients
2015, British Journal of Oral and Maxillofacial SurgeryCitation Excerpt :The estimated global incidence ranges from 0.4 to 13.5 cases/100,000 annually.3 The incidence of malignant tumours of the salivary gland varies from 0.4 to 2.6 cases/100,000 inhabitants.4 In China, they account for only about 2% of human tumours,5 and about 5% of all malignant tumours in the head and neck region,6,7 with an incidence of 1.0/100,000 person/year.